Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary chemotherapy: how does it compare with surgery?

A Horwich1

  • 1Institute of Cancer Research, Royal Marsden NHS Trust, Sutton, Surrey, United Kingdom.

Seminars in Urologic Oncology
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Appendix 9: Testicular seminoma and non-seminoma: eUpdate published online 29 June 2017 (www.esmo.org/Guidelines/Genitourinary-Cancers).

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers).

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same journal

The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies.

Seminars in urologic oncology·2002
Same journal

Poor prognosis germ-cell tumors: An unresolved challenge.

Seminars in urologic oncology·2002
Same journal

Chemotherapy for good-risk germ-cell tumors.

Seminars in urologic oncology·2002
Same journal

Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors.

Seminars in urologic oncology·2002
Same journal

Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated?

Seminars in urologic oncology·2002
Same journal

Controversies in the management of testicular seminoma.

Seminars in urologic oncology·2002
See all related articles

Primary chemotherapy after orchidectomy offers a high cure rate for metastatic nonseminoma, comparable to retroperitoneal lymph node dissection. This approach provides a viable alternative for stage II testicular cancer patients.

Area of Science:

  • Oncology
  • Urologic Oncology
  • Medical Oncology

Background:

  • Testicular nonseminoma with small-volume metastases often requires multimodal treatment.
  • Retroperitoneal lymph node dissection (RPLND) has been a standard treatment, but carries risks.
  • Primary chemotherapy presents a potential alternative treatment modality.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of primary chemotherapy followed by orchidectomy for stage II testicular nonseminoma.
  • To compare the cure rates and side effects of primary chemotherapy versus RPLND.

Main Methods:

  • Retrospective analysis of 122 patients with stage II testicular nonseminoma treated at a single institution.
  • Patients received primary chemotherapy followed by orchidectomy.

Related Experiment Videos

  • A subset of patients underwent postchemotherapy retroperitoneal lymph node dissection.

    • Main Results:

    • The 5-year survival rate was 97% in the overall cohort.
    • 35 patients had postchemotherapy lymphadenectomy, with only 5 experiencing loss of ejaculation.
    • Primary chemotherapy demonstrated comparable cure rates to RPLND.

    Conclusions:

    • Primary chemotherapy following orchidectomy is an effective treatment for small-volume metastatic nonseminoma.
    • This approach offers a high cure rate and survival benefit for stage II testicular nonseminoma.
    • Primary chemotherapy is a reasonable and potentially less morbid alternative to RPLND.